Immediate Impact
1 from Science/Nature 67 standout
Citing Papers
Multidrug-resistant tuberculosis
2024 Standout
Drug-resistant tuberculosis: a persistent global health concern
2024 Standout
Works of Olivier Lapujade being referenced
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
2014
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Olivier Lapujade | 254 | 100 | 47 | 208 | 105 | 4 | 433 | |
| Isis A. Mikhail | 147 | 117 | 14 | 181 | 78 | 12 | 459 | |
| Smego Ra | 216 | 105 | 10 | 178 | 171 | 15 | 505 | |
| Simon Paul | 221 | 38 | 6 | 286 | 59 | 8 | 461 | |
| Ingrid K. Blomquist | 196 | 65 | 19 | 169 | 94 | 11 | 438 | |
| E. Dale Everett | 181 | 114 | 20 | 85 | 54 | 10 | 511 | |
| Gysje J. Pontororing | 273 | 79 | 30 | 210 | 80 | 9 | 472 | |
| T T Hien | 120 | 51 | 12 | 107 | 248 | 8 | 463 | |
| Maria E. Rafael | 232 | 54 | 37 | 151 | 94 | 7 | 425 | |
| C Gakis | 92 | 72 | 6 | 103 | 26 | 6 | 403 | |
| Renald Hennig | 145 | 31 | 38 | 188 | 65 | 12 | 472 |
All Works
Loading papers...